Related factors to disparity of diabetes care in Iran

Medical Science Monitor

Volumn 15, Issue 5, 2009, Pages

  Mirzazadeh, Ali ^a   Baradaran, Hamid R ^b   Haghdoost, Ali A ^a   Salari, Pooria ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glycemic control; Iran; Type 2 diabetes

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE SYSTEM; HEALTH SURVEY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; URBAN AREA;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; SOCIAL JUSTICE;

EID: 66649136700     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Yach D, Stuckler D, Brownell KD: Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med., 2006; 12: 62-66 (Pubitemid 43050076)
2. Wild S, Roglic G, Green A et al: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004; 27: 1047-1053
3. Esteghamati A, Gouya MM, Abbasi M et al: Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care, 2008; 31: 96-98
4. Zimmet P: Diabetes epidemiology as a trigger to diabetes research. Diabetologia, 1999; 42: 499-518 (Pubitemid 29195999)
5. Trivedi A, Zaslavsky A, Schneider E, Ayanian J: Relationship between quality of care and racial disparities in Medicare health plans. JAMA, 2006; 296: 998-1004 (Pubitemid 44631446)
6. Lanting L, Joung I, Mackenbach J et al: Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care, 2005; 28: 2280-2288 (Pubitemid 41242485)
7. WHO: STEPS Manual, Using the STEPS Manual; in http://www.who.int/ chp/steps/manual/en/index.html. WHO, 2008
8. Delavari A, Alikhani S, Alaedini F: A national profile of non-communicable disease risk factors in the I.R.of Iran; Also available through http://www.ncdinfobase.ir/docs.asp: Center for Disease, 2005
9. Morrish NJ SL, Fuller JH, Keen H, Jarrett RJ: Incidence of macrovascular disease in diabetes mellitus: the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia, 1991; 34: 584-589
10. de Grauw WJ vdLE, van den Hoogen HJ, van Weel C: Cardiovascular morbidity and mortality in type 2 diabetic patients: a 22-year historical cohort study in Dutch general practice. Diabet Med, 1995; 12: 117-122
11. Nicholas L, Smith CM: The Burden of Diabetes-Associated Cardiovascular Hospitalizations in Veterans Administration (VA) and Non-VA Medical Facilities. Diabetes Care, 2004; 27: B27-32
12. Kim S: Burden of hospitalizations primarily due to uncontrolled diabetes: implications of inadequate primary health care in the United States. Diabetes Care, 2007; 30: 1281-1282 (Pubitemid 46684664)
13. Gregg EW, Cadwell BL, Cheng YJ et al: Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the US. Diabetes Care, 2004; 27: 2806-2812 (Pubitemid 39565041)
14. Azizi F: Diabetes mellitus in the Islamic Republic of Iran. IDF Bulletin, 1996; 3: 38-39
15. Azizi F SN, Salehi P, Emami H: Glucose intolerance and cardiovascular risk factors in Tehran urban population: "Tehran Lipid and Glucose Study". IJEM, 2001; 12: 256-257
16. Amini MBN, Afshinnia F, Shahirian M, Kazemi M: the prevalence of diabetes mellitus in Isfahan. Pajouhesh Dar Pezeshki, 1998; 22: 11-18
17. Trief P, Grant W, Elbert K, Weinstock R: Family environment, glycemic control, and the psychosocial adaptation of adults with diabetes. Diabetes Care, 1998; 21: 241-245 (Pubitemid 28079431)
18. Garay-Sevilla M, Nara L, Malacara J et al: Adherence to treatment and social support in patients with NIDDM. J Diabetes Complications, 1995; 9: 81-86
19. Trief PM, Himes CL, Orendorff R, Weinstock RS: The marital relationship and psychosocial adaptation and glycemic control of individuals with diabetes. Diabetes Care, 2001; 24: 1384-1389 (Pubitemid 33716425)
20. Correa-de-Araujo R, McDermott K, Moy E: Gender differences accross racial and ethinic groups in the quality of care for diabetes. Women's Health Issues, 2006; 16: 56-65
21. American Diabetes Association: Standards of Medical Care in Diabetes. Diabetes Care, 2006; 29: 7
22. Golembiewska E: [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities]. Ann Acad Med Stetin, 2004; 50: 131-138
23. Barr RG, Nathan DM, Meigs JB, Singer DE: Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med, 2002; 137: 263-272
24. Bryson CL, Boyko EJ: Review: glycated haemoglobin A1c and fasting plasma glucose screening tests have similar sensitivities and specificities for early detection of type 2 diabetes. Evid Based Med., 2007; 12: 152 (Pubitemid 47611225)
25. Jimenez-Moleon J, Bueno-Cavanillas A, Luna-Del-Castillo J et al: Prevalence of gestational diabetes mellitus: variations related to screening strategy used. Eur J Endocrinol, 2002; 146: 831-837 (Pubitemid 34705076)